IDiyas

For the Inventor, By the Inventor

Solon, OH, United States of America

Amin Mohammed Khan

USPTO Granted Patents = 9 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 26(Granted Patents)


Location History:

  • Toledo, OH (US) (1995 - 1997)
  • Solon, OH (US) (1997 - 2000)

Company Filing History:

goldMedal5 out of 359 
 
University of Toledo
 patents
silverMedal5 out of 17 
 
Gliatech, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1995-2000

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6072057 - 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 (2000-06-06),
2. 6008240 - 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives (1999-12-28),
3. 5990317 - 2-(1H-4(5)-imidazoyl) cyclopropyl compounds (1999-11-23),
4. 5663350 - Process for the preparation of intermediates useful for the synthesis of (1997-09-02),
5. 5652258 - 2-(4-imidazoyl) cyclopropyl derivatives (1997-07-29),
6. 5639775 - 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H.sub.3 (1997-06-17),
7. 5633382 - Histamine H.sub.3 -receptor antagonists and therapeutic uses thereof (1997-05-27),
8. 5486526 - Histamine H.sub.3 -receptor antagonists and therapeutic uses thereof (1996-01-23),
9. 5380858 - Process for the preparation of intermediates useful for the synthesis of (1995-01-10),

Title: Innovations of Amin Mohammed Khan

Introduction

Amin Mohammed Khan is a notable inventor based in Solon, Ohio. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of nine patents to his name, Khan's work reflects a commitment to advancing scientific knowledge and innovation.

Latest Patents

One of Khan's latest patents includes the invention of 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor antagonists. This invention provides compounds that exhibit H3 histamine receptor antagonist activity, characterized by a general formula that includes various substituents. The compounds are designed to have specific properties that may be beneficial in medical applications.

Career Highlights

Throughout his career, Amin Mohammed Khan has worked with esteemed institutions, including the University of Toledo and Gliatech, Inc. His experience in these organizations has allowed him to collaborate with other professionals and contribute to groundbreaking research in his field.

Collaborations

Khan has collaborated with notable colleagues such as Graham J. Durant and Clark E. Tedford. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Amin Mohammed Khan's innovative work and numerous patents highlight his significant contributions to the field of chemistry. His dedication to research and development continues to inspire advancements in therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…